Erythropoiesis stimulating agents approaches to modulate activity

Angus M Sinclair Amgen Inc, Thousand Oaks, CA, USA Abstract: Recombinant human erythropoietin (rHuEPO), such as the approved agents epoetin alfa and epoetin beta, has been used successfully for over 20 years to treat anemia in millions of patients. However, due to the relatively short half-life of t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Sinclair AM
Format: article
Langue:EN
Publié: Dove Medical Press 2013
Sujets:
Accès en ligne:https://doaj.org/article/c50b66a52a4947e6b18f0a2108cca0f7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!